About LeMaitre Vascular (NASDAQ:LMAT)
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and Reddick cholangiogram catheters to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LMAT
CUSIPN/A
Phone781-221-2266
Debt
Debt-to-Equity RatioN/A
Current Ratio6.09%
Quick Ratio4.50%
Price-To-Earnings
Trailing P/E Ratio45.36
Forward P/E Ratio39.81
P/E Growth2.73
Sales & Book Value
Annual Sales$100.87 million
Price / Sales7.46
Cash Flow$1.0729 per share
Price / Cash36.36
Book Value$5.70 per share
Price / Book6.84
Profitability
EPS (Most Recent Fiscal Year)$0.86
Net Income$17.17 million
Net Margins17.03%
Return on Equity16.93%
Return on Assets14.74%
Miscellaneous
Employees423
Outstanding Shares19,300,000
LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions
What is LeMaitre Vascular's stock symbol?
LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."
How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?
LeMaitre Vascular announced a quarterly dividend on Friday, February 23rd. Stockholders of record on Thursday, March 22nd will be paid a dividend of $0.07 per share on Thursday, April 5th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date is Wednesday, March 21st. This is a positive change from LeMaitre Vascular's previous quarterly dividend of $0.06. View LeMaitre Vascular's Dividend History.
How will LeMaitre Vascular's stock buyback program work?
LeMaitre Vascular announced that its board has authorized a stock repurchase program on Friday, July 28th 2017, which authorizes the company to repurchase $7,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 1.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board believes its stock is undervalued.
How were LeMaitre Vascular's earnings last quarter?
LeMaitre Vascular, Inc. (NASDAQ:LMAT) released its quarterly earnings results on Wednesday, February, 21st. The medical instruments supplier reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.01. The medical instruments supplier had revenue of $26.15 million for the quarter, compared to analysts' expectations of $26.23 million. LeMaitre Vascular had a return on equity of 16.93% and a net margin of 17.03%. The company's revenue for the quarter was up 12.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.13 earnings per share. View LeMaitre Vascular's Earnings History.
When is LeMaitre Vascular's next earnings date?
What guidance has LeMaitre Vascular issued on next quarter's earnings?
LeMaitre Vascular updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $1.05-1.13 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.98. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $111.05 million.LeMaitre Vascular also updated its Q2 guidance to $0.41-0.43 EPS.
What price target have analysts set for LMAT?
5 brokerages have issued 12-month target prices for LeMaitre Vascular's shares. Their forecasts range from $31.00 to $34.00. On average, they anticipate LeMaitre Vascular's share price to reach $32.50 in the next year. View Analyst Ratings for LeMaitre Vascular.
Who are some of LeMaitre Vascular's key competitors?
Some companies that are related to LeMaitre Vascular include NuVasive (NUVA), Nevro (NVRO), Merit Medical Systems (MMSI), NovoCure (NVCR), Irhythm Technologies (IRTC), Mazor Robotics (MZOR), Intersect ENT (XENT), ATRION (ATRI), Orthofix (OFIX), OraSure Technologies (OSUR), Glaukos (GKOS), Luminex (LMNX), K2M Group (KTWO), MiMedx Group (MDXG) and CryoLife (CRY).
Who are LeMaitre Vascular's key executives?
LeMaitre Vascular's management team includes the folowing people:
- Mr. George W. LeMaitre, Chairman & CEO (Age 53)
- Mr. David B. Roberts, Pres and Director (Age 54)
- Mr. Joseph P. Pellegrino Jr., CFO, Treasurer, Sec. & Director (Age 53)
- Dr. George D. LeMaitre M.D., FACS, Founder and Chairman of Scientific Advisory Board (Age 84)
- Mr. Trent G. Kamke, Sr. VP of Operations (Age 47)
Has LeMaitre Vascular been receiving favorable news coverage?
Media coverage about LMAT stock has trended somewhat positive recently, according to Accern Sentiment. The research firm scores the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. LeMaitre Vascular earned a coverage optimism score of 0.09 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 46.38 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of LeMaitre Vascular?
Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is LeMaitre Vascular's stock price today?
One share of LMAT stock can currently be purchased for approximately $39.01.
How big of a company is LeMaitre Vascular?
LeMaitre Vascular has a market capitalization of $773.15 million and generates $100.87 million in revenue each year. The medical instruments supplier earns $17.17 million in net income (profit) each year or $0.86 on an earnings per share basis. LeMaitre Vascular employs 423 workers across the globe.
How can I contact LeMaitre Vascular?
LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.
MarketBeat Community Rating for LeMaitre Vascular (LMAT)
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe LMAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
LeMaitre Vascular (NASDAQ:LMAT) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for LeMaitre Vascular in the last 12 months. Their average twelve-month price target is $32.50, suggesting that the stock has a possible downside of 16.69%. The high price target for LMAT is $34.00 and the low price target for LMAT is $31.00. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.20 | 2.20 | 2.17 | 2.17 |
| Ratings Breakdown: | 0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $32.50 | $32.50 | $31.50 | $31.50 |
| Price Target Upside: | 16.69% downside | 9.19% downside | 0.77% upside | 0.77% upside |
LeMaitre Vascular (NASDAQ:LMAT) Consensus Price Target History
LeMaitre Vascular (NASDAQ:LMAT) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
LeMaitre Vascular (NASDAQ:LMAT) Dividend Information
LeMaitre Vascular pays an annual dividend of $0.28 per share, with a dividend yield of 0.72%. LMAT's most recent quarterly dividend payment was Thursday, April 5. LeMaitre Vascular pays out 32.56% of its earnings out as a dividend.
| Most Recent Dividend: | 4/5/2018 |
| Annual Dividend: | $0.28 |
| Dividend Yield: | 0.72% |
| Payout Ratio: | 32.56% (Trailing 12 Months of Earnings)
28.57% (Based on This Year's Estimates)
25.00% (Based on Next Year's Estimates)
|
LeMaitre Vascular (NASDAQ:LMAT) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/23/2018 | quarterly | $0.07 | 0.78% | 3/21/2018 | 3/22/2018 | 4/5/2018 |
| 10/30/2017 | quarterly | $0.0550 | 0.71% | 11/21/2017 | 11/22/2017 | 12/7/2017 |
| 7/28/2017 | quarterly | $0.0550 | 0.64% | 8/21/2017 | 8/23/2017 | 9/7/2017 |
| 4/28/2017 | quarterly | $0.0550 | 0.74% | 5/22/2017 | 5/24/2017 | 6/8/2017 |
| 2/23/2017 | quarterly | $0.0550 | 1% | 3/20/2017 | 3/22/2017 | 4/6/2017 |
| 10/27/2016 | quarterly | $0.0450 | 0.85% | 11/17/2016 | 11/21/2016 | 12/5/2016 |
| 7/29/2016 | quarterly | $0.0450 | 1.05% | 8/18/2016 | 8/22/2016 | 9/6/2016 |
| 5/4/2016 | quarterly | $0.0450 | 1.12% | 5/23/2016 | 5/25/2016 | 6/8/2016 |
| 2/25/2016 | quarterly | $0.0450 | 1.19% | 3/17/2016 | 3/21/2016 | 4/4/2016 |
| 10/29/2015 | quarterly | $0.04 | 1.11% | 11/18/2015 | 11/20/2015 | 12/4/2015 |
| 7/29/2015 | quarterly | $0.04 | 1.25% | 8/18/2015 | 8/20/2015 | 9/3/2015 |
| 4/29/2015 | quarterly | $0.04 | 1.85% | 5/20/2015 | 5/22/2015 | 6/5/2015 |
| 2/26/2015 | quarterly | $0.04 | 2.03% | 3/18/2015 | 3/20/2015 | 4/3/2015 |
| 10/28/2014 | quarterly | $0.0350 | 1.93% | 11/18/2014 | 11/20/2014 | 12/4/2014 |
| 7/31/2014 | quarterly | $0.0350 | 1.73% | 8/19/2014 | 8/21/2014 | 9/4/2014 |
| 4/30/2014 | quarterly | $0.0350 | 1.71% | 5/20/2014 | 5/22/2014 | 6/5/2014 |
| 2/26/2014 | quarterly | $0.0350 | 1.75% | 3/18/2014 | 3/20/2014 | 4/3/2014 |
| 10/31/2013 | quarterly | $0.03 | 1.49% | 11/18/2013 | 11/20/2013 | 12/4/2013 |
| 7/30/2013 | quarterly | $0.03 | 1.73% | 8/19/2013 | 8/21/2013 | 9/4/2013 |
| 5/2/2013 | quarterly | $0.03 | 1.98% | 5/20/2013 | 5/22/2013 | 6/5/2013 |
| 2/27/2013 | quarterly | $0.03 | 1.92% | 3/18/2013 | 3/20/2013 | 4/3/2013 |
(Data available from 1/1/2013 forward)
LeMaitre Vascular (NASDAQ LMAT) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 72.78%
LeMaitre Vascular (NASDAQ LMAT) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/7/2018 | George W Lemaitre | Chairman | Sell | 30,000 | $36.19 | $1,085,700.00 | 3,180,709 |  |
| 3/5/2018 | George W Lemaitre | Chairman | Sell | 45,000 | $34.66 | $1,559,700.00 | 3,225,709 | |
| 3/2/2018 | George W Lemaitre | CEO | Sell | 15,000 | $34.55 | $518,250.00 | 3,225,709 | |
| 2/28/2018 | George W Lemaitre | CEO | Sell | 5,700 | $35.56 | $202,692.00 | 3,259,263 | |
| 2/26/2018 | George W Lemaitre | CEO | Sell | 42,036 | $35.68 | $1,499,844.48 | 3,259,263 | |
| 11/6/2017 | David B Roberts | Insider | Sell | 4,123 | $32.14 | $132,513.22 | 24,482 | |
| 8/30/2017 | David B Roberts | Insider | Sell | 26,683 | $36.67 | $978,465.61 | 48,108 | |
| 8/30/2017 | George W Lemaitre | CEO | Sell | 15,000 | $37.13 | $556,950.00 | 3,325,508 | |
| 8/29/2017 | George W Lemaitre | CEO | Sell | 15,000 | $36.72 | $550,800.00 | 3,325,508 | |
| 8/28/2017 | George W Lemaitre | CEO | Sell | 30,000 | $36.43 | $1,092,900.00 | 3,325,508 | |
| 8/25/2017 | George W Lemaitre | Chairman | Sell | 40,000 | $33.89 | $1,355,600.00 | 3,390,508 | |
| 8/24/2017 | George W Lemaitre | CEO | Sell | 15,000 | $33.97 | $509,550.00 | 3,390,508 | |
| 8/23/2017 | George W Lemaitre | CEO | Sell | 5,000 | $33.91 | $169,550.00 | 3,390,508 | |
| 8/17/2017 | Lawrence J Jasinski | Director | Sell | 2,030 | $34.23 | $69,486.90 | 8,333 | |
| 8/11/2017 | George W Lemaitre | Chairman | Sell | 21,300 | $32.90 | $700,770.00 | 3,405,508 | |
| 8/10/2017 | George W Lemaitre | CEO | Sell | 11,300 | $32.79 | $370,527.00 | 3,405,508 | |
| 8/9/2017 | George W Lemaitre | Chairman | Sell | 30,000 | $33.65 | $1,009,500.00 | 3,436,808 | |
| 8/8/2017 | George W Lemaitre | CEO | Sell | 10,000 | $34.02 | $340,200.00 | 3,436,808 | |
| 8/7/2017 | George W Lemaitre | CEO | Sell | 10,000 | $33.62 | $336,200.00 | 3,436,808 | |
| 8/7/2017 | Peter R Gebauer | Insider | Sell | 6,224 | $33.85 | $210,682.40 | 8,477 | |
| 8/4/2017 | David B Roberts | Insider | Sell | 48,317 | $33.12 | $1,600,259.04 | 30,105 | |
| 8/3/2017 | George W Lemaitre | Chairman | Sell | 58,700 | $33.97 | $1,994,039.00 | 3,471,808 | |
| 8/3/2017 | Peter R Gebauer | Insider | Sell | 22,067 | $34.28 | $756,456.76 | 4,486 | |
| 8/1/2017 | Lawrence J Jasinski | Director | Sell | 6,500 | $34.47 | $224,055.00 | 12,863 | |
| 6/1/2017 | Michael T Wijas | VP | Sell | 2,346 | $31.42 | $73,711.32 | 3,584 | |
| 5/24/2017 | Trent G Kamke | Insider | Sell | 15,780 | $30.28 | $477,818.40 | 31,341 | |
| 5/18/2017 | George W Lemaitre | Chairman | Sell | 21,225 | $30.11 | $639,084.75 | 3,386,295 | |
| 5/11/2017 | David B Roberts | Insider | Sell | 39,531 | $30.37 | $1,200,556.47 | 7,414 | |
| 5/10/2017 | George W Lemaitre | Chairman | Sell | 63,622 | $30.98 | $1,971,009.56 | 3,450,815 | |
| 5/9/2017 | George W Lemaitre | CEO | Sell | 34,517 | $30.67 | $1,058,636.39 | 3,450,815 | |
| 5/8/2017 | George W Lemaitre | CEO | Sell | 9,102 | $31.12 | $283,254.24 | 3,450,815 | |
| 5/4/2017 | David B Roberts | Insider | Sell | 44,340 | $31.14 | $1,380,747.60 | 46,945 | |
| 5/3/2017 | George W Lemaitre | Chairman | Sell | 87,342 | $32.35 | $2,825,513.70 | 3,484,149 | |
| 3/10/2017 | David B Roberts | Insider | Sell | 5,900 | $22.44 | $132,396.00 | 46,945 | |
| 3/1/2017 | George W Lemaitre | Chairman | Sell | 10,000 | $22.36 | $223,600.00 | 3,451,694 | |
| 2/28/2017 | George W Lemaitre | CEO | Sell | 3,000 | $22.27 | $66,810.00 | 3,451,694 | |
| 2/27/2017 | George W Lemaitre | CEO | Sell | 5,000 | $22.31 | $111,550.00 | 3,451,694 | |
| 9/16/2016 | David B Roberts | Insider | Sell | 6,452 | $21.05 | $135,814.60 | 69,793 | |
| 9/15/2016 | David B Roberts | Insider | Sell | 33,548 | $20.41 | $684,714.68 | 79,793 | |
| 9/8/2016 | George W Lemaitre | Chairman | Sell | 30,000 | $20.48 | $614,400.00 | 3,395,063 | |
| 9/7/2016 | David B Roberts | Insider | Sell | 20,000 | $20.07 | $401,400.00 | 119,793 | |
| 9/2/2016 | George W Lemaitre | Chairman | Sell | 60,037 | $18.30 | $1,098,677.10 | 3,443,098 | |
| 8/30/2016 | Peter R Gebauer | Insider | Sell | 3,431 | $18.20 | $62,444.20 | 31,283 | |
| 8/29/2016 | Peter R Gebauer | Insider | Sell | 26,815 | $17.78 | $476,770.70 | 31,283 | |
| 8/24/2016 | David B Roberts | Insider | Sell | 10,000 | $17.35 | $173,500.00 | 134,793 | |
| 8/24/2016 | George W Lemaitre | CEO | Sell | 6,800 | $17.49 | $118,932.00 | 3,491,564 | |
| 8/23/2016 | George W Lemaitre | CEO | Sell | 19,664 | $17.43 | $342,743.52 | 3,491,564 | |
| 8/22/2016 | George W Lemaitre | CEO | Sell | 8,927 | $17.39 | $155,240.53 | 3,491,564 | |
| 8/19/2016 | Cornelia W Lemaitre | Director | Sell | 5,000 | $17.15 | $85,750.00 | 188,858 | |
| 8/18/2016 | Cornelia W Lemaitre | Director | Sell | 22,500 | $17.36 | $390,600.00 | 188,858 | |
| 8/15/2016 | Cornelia W Lemaitre | Director | Sell | 22,500 | $17.36 | $390,600.00 | 188,858 | |
| 8/15/2016 | George W Lemaitre | Chairman | Sell | 15,896 | $17.53 | $278,656.88 | 3,512,839 | |
| 8/9/2016 | George W Lemaitre | Chairman | Sell | 5,460 | $17.41 | $95,058.60 | 3,516,387 | |
| 8/9/2016 | Lawrence J Jasinski | Director | Sell | 7,500 | $17.60 | $132,000.00 | 12,863 | |
| 8/5/2016 | David B Roberts | Insider | Sell | 10,000 | $17.63 | $176,300.00 | 140,493 | |
| 8/4/2016 | George W Lemaitre | Chairman | Sell | 4,540 | $17.65 | $80,131.00 | 3,516,387 | |
| 7/28/2016 | Peter R Gebauer | Insider | Sell | 30,000 | $16.47 | $494,100.00 | 25,374 | |
| 6/8/2016 | George W Lemaitre | CEO | Sell | 19,189 | $15.01 | $288,026.89 | 3,521,849 | |
| 6/7/2016 | George W Lemaitre | CEO | Sell | 9,100 | $15.02 | $136,682.00 | 3,521,849 | |
| 6/6/2016 | George W Lemaitre | CEO | Sell | 900 | $15.06 | $13,554.00 | 3,521,849 | |
| 6/6/2016 | Peter R Gebauer | Insider | Sell | 6,310 | $14.96 | $94,397.60 | 53,339 | |
| 6/3/2016 | Lawrence J Jasinski | Director | Sell | 4,924 | $14.99 | $73,810.76 | 12,787 | |
| 6/3/2016 | Trent G Kamke | Insider | Sell | 2,510 | $15.00 | $37,650.00 | 15,573 | |
| 5/25/2016 | Lawrence J Jasinski | Director | Sell | 6,326 | $15.30 | $96,787.80 | 15,642 | |
| 5/25/2016 | Trent G Kamke | Insider | Sell | 1,524 | $15.25 | $23,241.00 | 18,183 | |
| 5/23/2016 | Trent G Kamke | Insider | Sell | 16,465 | $15.02 | $247,304.30 | 12,204 | |
| 5/18/2016 | George W Lemaitre | CEO | Sell | 2,944 | $15.23 | $44,837.12 | 3,522,749 | |
| 5/17/2016 | Trent G Kamke | Insider | Sell | 2,400 | $15.51 | $37,224.00 | 20,492 | |
| 5/16/2016 | George W Lemaitre | CEO | Sell | 1,740 | $15.49 | $26,952.60 | 3,522,749 | |
| 5/13/2016 | George W Lemaitre | CEO | Sell | 7,451 | $15.45 | $115,117.95 | 3,522,749 | |
| 5/9/2016 | George W Lemaitre | CEO | Sell | 110,189 | $16.17 | $1,781,756.13 | 3,549,133 | |
| 5/6/2016 | David B Roberts | Director | Sell | 17,064 | $15.89 | $271,146.96 | 162,434 | |
| 5/5/2016 | Trent G Kamke | Insider | Sell | 3,327 | $16.10 | $53,564.70 | 22,692 | |
| 4/18/2016 | David B Roberts | Director | Sell | 1,766 | $16.10 | $28,432.60 | 147,136 | |
| 4/4/2016 | David B Roberts | Director | Sell | 17,444 | $15.99 | $278,929.56 | 107,605 | |
| 2/25/2016 | David B Roberts | Director | Sell | 2,690 | $15.91 | $42,797.90 | 125,049 | |
| 1/14/2016 | David B. Roberts | Director | Sell | 12,867 | $15.85 | $203,941.95 | 127,739 | |
| 1/11/2016 | David B Roberts | Director | Sell | 27,490 | $15.68 | $431,043.20 | 140,606 | |
| 1/8/2016 | David B Roberts | Director | Sell | 2,743 | $15.51 | $42,543.93 | 168,096 | |
| 12/9/2015 | Joseph P. Pellegrino, Jr. | CFO | Sell | 14,348 | $16.01 | $229,711.48 | 110,389 | |
| 12/4/2015 | Peter R. Gebauer | insider | Sell | 12,816 | $15.53 | $199,032.48 | 70,420 | |
| 12/1/2015 | Peter R. Gebauer | insider | Sell | 37,184 | $15.73 | $584,904.32 | 70,420 | |
| 11/25/2015 | David B. Roberts | Director | Sell | 10,000 | $15.96 | $159,600.00 | 170,839 | |
| 11/24/2015 | Cornelia W Lemaitre | Director | Sell | 41,135 | $15.61 | $642,117.35 | 182,595 | |
| 11/23/2015 | George W. Lemaitre | CEO | Sell | 65,052 | $15.63 | $1,016,762.76 | 3,633,333 | |
| 11/23/2015 | Joseph P. Pellegrino, Jr. | CFO | Sell | 45,840 | $15.57 | $713,728.80 | 110,389 | |
| 11/23/2015 | Peter R. Gebauer | insider | Sell | 11,971 | $15.31 | $183,276.01 | 70,420 | |
| 11/20/2015 | David B. Roberts | Director | Sell | 10,000 | $14.73 | $147,300.00 | 180,839 | |
| 11/20/2015 | Peter R. Gebauer | insider | Sell | 19,900 | $14.40 | $286,560.00 | 70,420 | |
| 11/17/2015 | George W Lemaitre | CEO | Sell | 30,000 | $14.15 | $424,500.00 | 3,698,385 | |
| 11/16/2015 | Lawrence J. Jasinski | Director | Sell | 7,500 | $13.57 | $101,775.00 | 14,113 | |
| 11/10/2015 | George W. Lemaitre | CEO | Sell | 57,844 | $13.80 | $798,247.20 | 3,728,385 | |
| 11/9/2015 | George W. Lemaitre | CEO | Sell | 7,524 | $13.70 | $103,078.80 | 3,728,385 | |
| 11/6/2015 | George W. Lemaitre | CEO | Sell | 39,000 | $13.83 | $539,370.00 | 3,728,385 | |
| 10/30/2015 | George W. Lemaitre | CEO | Sell | 16,190 | $14.55 | $235,564.50 | 3,786,229 | |
| 10/28/2015 | Peter R. Gebauer | insider | Sell | 44,315 | $13.97 | $619,080.55 | 70,420 | |
| 9/25/2015 | Peter R. Gebauer | insider | Sell | 5,441 | $13.91 | $75,684.31 | 70,420 | |
| 9/18/2015 | George W. Lemaitre | CEO | Sell | 46,391 | $14.37 | $666,638.67 | 3,802,419 | |
| 9/17/2015 | George W. Lemaitre | CEO | Sell | 49,559 | $13.96 | $691,843.64 | 3,846,869 | |
| 8/31/2015 | Peter R. Gebauer | insider | Sell | 10,465 | $13.49 | $141,172.85 | 70,420 | |
| 8/27/2015 | George W. Lemaitre | CEO | Sell | 28,700 | $13.66 | $392,042.00 | 3,888,369 | |
| 8/26/2015 | Peter R. Gebauer | insider | Sell | 15,978 | $13.53 | $216,182.34 | 70,420 | |
| 8/20/2015 | David B Roberts | Director | Sell | 12,000 | $13.58 | $162,960.00 | 190,839 | |
| 8/19/2015 | Peter R. Gebauer | insider | Sell | 4,022 | $14.24 | $57,273.28 | 70,420 | |
| 8/13/2015 | George W Lemaitre | CEO | Sell | 33,059 | $13.41 | $443,321.19 | | |
| 5/19/2015 | Peter R Gebauer | Insider | Sell | 10,000 | $10.12 | $101,200.00 | | |
| 5/18/2015 | George W Lemaitre | CEO | Sell | 20,132 | $10.01 | $201,521.32 | | |
| 5/11/2015 | David B Roberts | Director | Sell | 15,000 | $10.31 | $154,650.00 | | |
| 5/7/2015 | George W Lemaitre | CEO | Sell | 70,984 | $9.72 | $689,964.48 | | |
| 5/6/2015 | David B Roberts | Director | Sell | 11,000 | $9.27 | $101,970.00 | | |
| 4/29/2015 | Peter R Gebauer | Insider | Sell | 15,332 | $8.99 | $137,834.68 | | |
| 4/16/2015 | Cornelia W Lemaitre | Director | Sell | 17,100 | $8.55 | $146,205.00 | | |
| 4/14/2015 | Cornelia W Lemaitre | Director | Sell | 6,707 | $8.42 | $56,472.94 | | |
| 3/31/2015 | Cornelia W Lemaitre | Director | Sell | 819 | $8.37 | $6,855.03 | | |
| 3/30/2015 | Cornelia W Lemaitre | Director | Sell | 31 | $8.36 | $259.16 | | |
| 3/25/2015 | Cornelia W Lemaitre | Director | Sell | 3,678 | $8.33 | $30,637.74 | | |
| 3/24/2015 | Cornelia W Lemaitre | Director | Sell | 3,373 | $8.33 | $28,097.09 | | |
| 3/23/2015 | Cornelia W Lemaitre | Director | Sell | 26,026 | $8.21 | $213,673.46 | | |
| 3/18/2015 | Cornelia W Lemaitre | Director | Sell | 5,601 | $8.03 | $44,976.03 | | |
| 3/10/2015 | Peter R Gebauer | Insider | Sell | 10,000 | $8.15 | $81,500.00 | | |
| 3/9/2015 | Peter R Gebauer | Insider | Sell | 7,200 | $8.15 | $58,680.00 | | |
| 3/6/2015 | Cornelia W Lemaitre | Director | Sell | 6,065 | $8.20 | $49,733.00 | | |
| 3/3/2015 | David B Roberts | Director | Sell | 12,000 | $7.65 | $91,800.00 | | |
| 1/29/2015 | Peter R Gebauer | Insider | Sell | 16,919 | $7.91 | $133,829.29 | | |
| 1/26/2015 | George W Lemaitre | CEO | Sell | 3,486 | $7.85 | $27,365.10 | | |
| 1/26/2015 | Peter R Gebauer | Insider | Sell | 1,800 | $7.90 | $14,220.00 | | |
| 1/5/2015 | George W Lemaitre | CEO | Sell | 18,447 | $7.74 | $142,779.78 | | |
| 1/2/2015 | David B Roberts | Director | Sell | 7,000 | $7.31 | $51,170.00 | | |
| 12/30/2014 | George W Lemaitre | CEO | Sell | 18,067 | $7.58 | $136,947.86 | | |
| 12/29/2014 | George W Lemaitre | CEO | Sell | 5,058 | $7.59 | $38,390.22 | | |
| 12/26/2014 | George W Lemaitre | CEO | Sell | 6,693 | $7.53 | $50,398.29 | | |
| 12/24/2014 | George W Lemaitre | CEO | Sell | 2,900 | $7.60 | $22,040.00 | | |
| 12/10/2014 | George W Lemaitre | CEO | Sell | 1,117 | $7.40 | $8,265.80 | | |
| 12/9/2014 | David B Roberts | Director | Sell | 3,000 | $7.36 | $22,080.00 | | |
| 12/9/2014 | George W Lemaitre | CEO | Sell | 1,794 | $7.40 | $13,275.60 | | |
| 11/28/2014 | George W Lemaitre | CEO | Sell | 42,641 | $7.40 | $315,543.40 | | |
| 11/25/2014 | George W Lemaitre | CEO | Sell | 613 | $7.30 | $4,474.90 | | |
| 11/13/2014 | Trent G Kamke | Insider | Sell | 1,100 | $7.15 | $7,865.00 | | |
| 11/5/2014 | George W Lemaitre | CEO | Sell | 28,286 | $7.07 | $199,982.02 | | |
| 10/31/2014 | David B Roberts | President | Sell | 3,500 | $7.03 | $24,605.00 | | |
| 10/31/2014 | George W Lemaitre | CEO | Sell | 23,758 | $7.14 | $169,632.12 | | |
| 9/8/2014 | George W Lemaitre | CEO | Sell | 29,966 | $7.10 | $212,758.60 | | |
| 9/4/2014 | Lawrence J Jasinski | Director | Sell | 3,750 | $7.14 | $26,775.00 | | |
| 6/25/2014 | Cornelia W Lemaitre | Director | Sell | 4,700 | $8.32 | $39,104.00 | | |
| 5/7/2014 | David Roberts | President | Sell | 3,000 | $7.95 | $23,850.00 | 206,710 | |
| 3/7/2014 | Russell Hays | Director | Sell | 15,000 | $8.07 | $121,050.00 | | |
| 3/6/2014 | Cornelia Lemaitre | Director | Sell | 6,950 | $8.15 | $56,642.50 | 174,581 | |
| 3/6/2014 | Trent Kamke | Insider | Sell | 1,278 | $8.18 | $10,454.04 | 16,141 | |
| 3/4/2014 | Cornelia Lemaitre | Director | Sell | 12,845 | $8.29 | $106,485.05 | 174,581 | |
| 1/23/2014 | Cornelia Lemaitre | Director | Sell | 3,900 | $8.24 | $32,136.00 | 174,581 | |
| 11/1/2013 | David B Roberts | Director | Sell | 2,000 | $7.96 | $15,920.00 | | |
| 10/31/2013 | Cornelia W Lemaitre | Director | Sell | 20,000 | $7.88 | $157,600.00 | | |
| 10/25/2013 | Cornelia W Lemaitre | Director | Sell | 20,000 | $7.38 | $147,600.00 | | |
| 9/5/2013 | Joseph P Pellegrino Jr | CFO | Sell | 25,000 | $6.86 | $171,500.00 | | |
| 9/3/2013 | David B Roberts | Director | Sell | 6,500 | $6.90 | $44,850.00 | | |
| 8/14/2013 | Cornelia W Lemaitre | Director | Sell | 7,500 | $7.00 | $52,500.00 | | |
| 8/12/2013 | Trent G Kamke | Insider | Sell | 2,000 | $6.90 | $13,800.00 | | |
| 8/8/2013 | Trent G Kamke | Insider | Sell | 2,000 | $6.83 | $13,660.00 | | |
| 8/2/2013 | Russell D Hays | Director | Sell | 15,000 | $6.78 | $101,700.00 | | |
| 7/30/2013 | David B Roberts | Director | Sell | 12,403 | $6.85 | $84,960.55 | | |
| 7/29/2013 | Cornelia W Lemaitre | Director | Sell | 2,500 | $7.00 | $17,500.00 | | |
| 7/26/2013 | David B Roberts | Director | Sell | 9,100 | $6.77 | $61,607.00 | | |
| 6/24/2013 | David B Roberts | Director | Sell | 2,100 | $6.75 | $14,175.00 | | |
| 6/5/2013 | Robert V Linden | VP | Sell | 9,383 | $6.45 | $60,520.35 | | |
| 5/30/2013 | Cornelia W Lemaitre | Director | Sell | 10,000 | $6.50 | $65,000.00 | | |
| 11/27/2012 | Cornelia W Lemaitre | Director | Sell | 2,699 | $6.25 | $16,868.75 | | |
| 8/10/2012 | George D Lemaitre | Director | Sell | 5,862 | $6.45 | $37,809.90 | | |
(Data available from 1/1/2013 forward)
LeMaitre Vascular (NASDAQ LMAT) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | LeMaitre Vascular (LMAT) Issues Q2 Earnings Guidance
www.americanbankingnews.com - April 25 at 6:10 PM |
| LeMaitre Vascular (LMAT) Issues FY18 Earnings Guidance
www.americanbankingnews.com - April 25 at 6:10 PM |
 | LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
finance.yahoo.com - April 25 at 4:37 PM |
| LeMaitre Vascular, Inc. (LMAT) Expected to Post Quarterly Sales of $26.41 Million
www.americanbankingnews.com - April 25 at 2:30 AM |
| LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?
finance.yahoo.com - April 24 at 4:41 PM |
| LeMaitre Vascular (LMAT) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - April 23 at 8:16 PM |
| LeMaitre Vascular, Inc. (LMAT) Expected to Post Earnings of $0.20 Per Share
www.americanbankingnews.com - April 23 at 7:14 PM |
| LeMaitre Vascular (LMAT) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 20 at 10:45 AM |
| LeMaitre Vascular Inc (LMAT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 20 at 1:43 AM |
| LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018
finance.yahoo.com - April 18 at 4:43 PM |
| LeMaitre Vascular (LMAT) Cut to "Buy" at BidaskClub
www.americanbankingnews.com - April 16 at 9:16 AM |
| LeMaitre Vascular (LMAT) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 14 at 8:01 PM |
| LeMaitre Vascular, Inc. (LMAT) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - April 11 at 10:07 AM |
| LeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.41 Million
www.americanbankingnews.com - April 8 at 2:10 AM |
| Zacks: Brokerages Expect LeMaitre Vascular Inc (LMAT) to Announce $0.20 Earnings Per Share
www.americanbankingnews.com - April 6 at 7:16 PM |
 | Lemaitre Vascular (LMAT) Sells General Surgery Product Lines for $7.4M
www.streetinsider.com - April 6 at 9:55 AM |
| LeMaitre Vascular Divests General Surgery Product Lines
finance.yahoo.com - April 6 at 9:55 AM |
| LeMaitre Vascular (LMAT) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - April 5 at 1:11 PM |
| Head-To-Head Survey: Cryolife (CRY) vs. LeMaitre Vascular (LMAT)
www.americanbankingnews.com - April 5 at 3:23 AM |
| LeMaitre Vascular (LMAT) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 3 at 10:58 PM |
| BidaskClub Upgrades LeMaitre Vascular (LMAT) to Strong-Buy
www.americanbankingnews.com - April 3 at 11:00 AM |
| LeMaitre Vascular (LMAT) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 31 at 4:56 PM |
| Zacks Investment Research Downgrades LeMaitre Vascular (LMAT) to Hold
www.americanbankingnews.com - March 30 at 11:10 PM |
| LeMaitre Vascular (LMAT) Raised to "Sell" at BidaskClub
www.americanbankingnews.com - March 28 at 12:34 AM |
| LeMaitre Vascular Inc (LMAT) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 26 at 1:34 AM |
| LeMaitre Vascular (LMAT) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - March 25 at 9:49 AM |
| Zacks Investment Research Upgrades LeMaitre Vascular (LMAT) to "Buy"
www.americanbankingnews.com - March 24 at 7:20 PM |
| LeMaitre Vascular (LMAT) Cut to "Hold" at BidaskClub
www.americanbankingnews.com - March 24 at 4:30 PM |
| LeMaitre Vascular Inc (LMAT) Expected to Post Earnings of $0.20 Per Share
www.americanbankingnews.com - March 20 at 9:08 PM |
| Edited Transcript of LMAT earnings conference call or presentation 21-Feb-18 10:00pm GMT
finance.yahoo.com - March 20 at 4:20 PM |
| LeMaitre Vascular Inc Forecasted to Earn Q4 2018 Earnings of $0.28 Per Share (LMAT)
www.americanbankingnews.com - March 12 at 6:34 AM |
| LeMaitre Vascular (LMAT) Upgraded at BidaskClub
www.americanbankingnews.com - March 10 at 5:28 PM |
| Insider Selling: LeMaitre Vascular Inc (LMAT) Chairman Sells 30,000 Shares of Stock
www.americanbankingnews.com - March 8 at 6:29 PM |
| LeMaitre Vascular Inc (LMAT) Shares Sold by Ranger Investment Management L.P.
www.americanbankingnews.com - March 6 at 2:11 PM |
| LeMaitre Vascular Inc (LMAT) Shares Sold by AWM Investment Company Inc.
www.americanbankingnews.com - March 6 at 4:44 AM |
| Insider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 15,000 Shares of Stock
www.americanbankingnews.com - March 5 at 9:30 PM |
| LeMaitre Vascular Inc (LMAT) Chairman Sells $1,559,700.00 in Stock
www.americanbankingnews.com - March 5 at 9:11 PM |
| Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Quarterly Sales of $26.41 Million
www.americanbankingnews.com - March 5 at 3:44 AM |
| Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Earnings of $0.20 Per Share
www.americanbankingnews.com - March 3 at 5:24 PM |
| LeMaitre Vascular Inc (LMAT) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 1 at 1:26 AM |
| LeMaitre Vascular Inc (LMAT) CEO Sells $202,692.00 in Stock
www.americanbankingnews.com - March 1 at 12:38 AM |
| Insider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 42,036 Shares of Stock
www.americanbankingnews.com - March 1 at 12:20 AM |
| LeMaitre Vascular to Present at Upcoming Investor Conferences
finance.yahoo.com - February 28 at 9:25 AM |
| Comerica Bank Raises Holdings in LeMaitre Vascular Inc (LMAT)
www.americanbankingnews.com - February 27 at 6:00 AM |
| Q1 2018 EPS Estimates for LeMaitre Vascular Inc Lifted by Barrington Research (LMAT)
www.americanbankingnews.com - February 26 at 2:26 AM |
| LeMaitre Vascular's (LMAT) "Hold" Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - February 24 at 7:10 AM |
| LeMaitre Vascular Inc (LMAT) Declares Quarterly Dividend of $0.07
www.americanbankingnews.com - February 23 at 5:04 PM |
| LeMaitre Vascular (LMAT) Issues Earnings Results
www.americanbankingnews.com - February 22 at 10:50 AM |
| LeMaitre Vascular (LMAT) Releases FY18 Earnings Guidance
www.americanbankingnews.com - February 21 at 6:44 PM |
| LeMaitre Vascular (LMAT) Releases Q1 Earnings Guidance
www.americanbankingnews.com - February 21 at 6:44 PM |
LeMaitre Vascular (NASDAQ:LMAT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
LeMaitre Vascular (NASDAQ:LMAT) Income Statement, Balance Sheet and Cash Flow Statement
LeMaitre Vascular (NASDAQ LMAT) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
